Hepatitis B in China

被引：288
作者：
Liu, Jie [1 ]
Fan, Daiming [1 ]
机构：
[1] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China
来源：
LANCET | 2007年 / 369卷 / 9573期
关键词：
D O I：
10.1016/S0140-6736(07)60723-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1582 / 1583
页数：2
相关论文
共 11 条
  • [1] [Anonymous], CLIN MED J
  • [2] Cui FQ, 2006, CHIN J VACCINES IMMU, V12, P206
  • [3] Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
    Janssen, HLA
    van Zonneveld, M
    Senturk, H
    Zeuzem, S
    Akarca, US
    Cakaloglu, Y
    Simon, C
    So, TMJ
    Gerken, G
    de Man, RA
    Niesters, HGM
    Zondervan, P
    Hansen, B
    Schalm, SW
    [J]. LANCET, 2005, 365 (9454) : 123 - 129
  • [4] Jia Ji-dong, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P698
  • [5] Viral hepatitis B
    Lai, CL
    Ratziu, V
    Yuen, MF
    Poynard, T
    [J]. LANCET, 2003, 362 (9401) : 2089 - 2094
  • [6] Liang Xiao-feng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P655
  • [7] The maze of treatments for hepatitis B
    Lok, AS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26) : 2743 - 2746
  • [8] Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy
    Sung, JJY
    Wong, ML
    Bowden, S
    Liew, CT
    Hui, AY
    Wong, VWS
    Leung, NWY
    Locarnini, S
    Chan, HLY
    [J]. GASTROENTEROLOGY, 2005, 128 (07) : 1890 - 1897
  • [9] Wang X.J., 2004, DIS SURVEILLANCE, V19, P290
  • [10] Zhuang H, 2005, CHIN J INFECT DIS S, V23, P2
12